Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging

Documenti analoghi

• EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer
  di: van Driel, Pieter B.A.A., et al.
  Pubblicazione: (2016)
• Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session
  di: Deken, Marion M., et al.
  Pubblicazione: (2020)
• Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy
  di: Mashayekhi, Vida, et al.
  Pubblicazione: (2020)
• Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
  di: van Brussel, Aram S. A., et al.
  Pubblicazione: (2015)
• Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody
  di: van Driel, P.B.A.A., et al.
  Pubblicazione: (2013)